Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
Issuer Blackrock
Entity holding fund iShares IV Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF Ticker BTEC(USD) LSE
ETF Ticker BTEK(GBP) LSE
ETF Ticker 2B70(EUR) F
ETF Ticker 2B70.DE(EUR) CXE
ETF Ticker BTEC.LS(USD) CXE
ETF Ticker BTEK.LS(GBP) CXE
ETF Ticker BTEC.L(GBP) LSE
ETF Ticker BTEK.L(GBP) LSE

Holdings detail for TSVT

Stock Name	2Seventy Bio Inc
Ticker	TSVT(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US9013841070

Show aggregate TSVT holdings

News associated with TSVT

Deutsche Bank AG Sells 958,639 Shares of 2seventy bio, Inc. (NASDAQ:TSVT): Deutsche Bank AG cut its stake in shares of 2seventy bio, Inc. (NASDAQ:TSVT – Free Report) by 72.0% during the 4th quarter, Holdings Channel reports. The institutional investor owned 372,311 shares of the company’s stock after selling 958,639 shares during the quarter. Deutsche Bank AG’s holdings in 2seventy bio were worth $1,095,000 at the end […] - 2025-05-26 05:04:44
Barclays PLC Raises Stake in 2seventy bio, Inc. (NASDAQ:TSVT): Barclays PLC boosted its holdings in shares of 2seventy bio, Inc. (NASDAQ:TSVT – Free Report) by 12.7% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 90,795 shares of the company’s stock after purchasing an additional 10,201 shares during the period. Barclays PLC’s holdings in 2seventy bio […] - 2025-05-12 04:30:56
Weiss Ratings Reiterates Sell (D-) Rating for 2seventy bio (NASDAQ:TSVT): 2seventy bio (NASDAQ:TSVT – Get Free Report)‘s stock had its “sell (d-)” rating reaffirmed by research analysts at Weiss Ratings in a research note issued on Saturday,Weiss Ratings reports. Other equities research analysts also recently issued research reports about the company. Leerink Partners restated a “market perform” rating and set a $5.00 target price (down […] - 2025-05-12 02:14:48
2seventy bio (NASDAQ:TSVT) Receives “Sell (D-)” Rating from Weiss Ratings: 2seventy bio (NASDAQ:TSVT – Get Free Report)‘s stock had its “sell (d-)” rating restated by analysts at Weiss Ratings in a research report issued to clients and investors on Tuesday,Weiss Ratings reports. Several other brokerages have also recently commented on TSVT. Leerink Partners reaffirmed a “market perform” rating and issued a $5.00 target price (down […] - 2025-04-09 03:08:53
10,939 Shares in 2seventy bio, Inc. (NASDAQ:TSVT) Acquired by China Universal Asset Management Co. Ltd.: China Universal Asset Management Co. Ltd. purchased a new position in 2seventy bio, Inc. (NASDAQ:TSVT – Free Report) during the fourth quarter, HoldingsChannel reports. The fund purchased 10,939 shares of the company’s stock, valued at approximately $32,000. Other institutional investors and hedge funds have also modified their holdings of the company. Erste Asset Management GmbH […] - 2025-02-05 06:46:53

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) TSVT holdings

Date	Number of TSVT Shares Held	Base Market Value of TSVT Shares	Local Market Value of TSVT Shares	Change in TSVT Shares Held	Change in TSVT Base Value	Current Price per TSVT Share Held	Previous Price per TSVT Share Held

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of TSVT by Blackrock for IE00BYXG2H39

Show aggregate share trades of TSVT

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-04-23 BUY 84 4.990* 3.53
2025-04-10 SELL -672 4.960* 3.33 Profit of 2,237 on sale
2025-04-08 SELL -84 4.890* 3.28 Profit of 275 on sale
2025-04-07 SELL -84 4.950* 3.25 Profit of 273 on sale
2025-04-04 SELL -420 4.950* 3.23 Profit of 1,355 on sale
2025-04-01 BUY 336 4.950* 3.17
2025-03-31 SELL -252 4.940* 3.14 Profit of 791 on sale
2025-03-14 SELL -1,360 4.950* 2.72 Profit of 3,702 on sale
2025-03-07 SELL -170 2.660* 2.57 Profit of 436 on sale
2025-03-04 SELL -85 2.600* 2.55 Profit of 217 on sale
2025-02-25 BUY 170 2.620* 2.55
2025-02-19 SELL -85 2.570* 2.54 Profit of 216 on sale
2025-02-13 BUY 255 2.550* 2.55
2025-02-12 BUY 85 2.390* 2.55
2025-02-11 BUY 340 2.330* 2.56
2025-01-17 BUY 340 2.610* 2.57
2025-01-16 BUY 340 2.440* 2.59
2025-01-10 SELL -170 2.490* 2.78 Profit of 473 on sale
2025-01-08 SELL -340 2.690* 2.96 Profit of 1,006 on sale
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-04-23	BUY	84	4.990*	3.53
2025-04-10	SELL	-672	4.960*	3.33 Profit of 2,237 on sale
2025-04-08	SELL	-84	4.890*	3.28 Profit of 275 on sale
2025-04-07	SELL	-84	4.950*	3.25 Profit of 273 on sale
2025-04-04	SELL	-420	4.950*	3.23 Profit of 1,355 on sale
2025-04-01	BUY	336	4.950*	3.17
2025-03-31	SELL	-252	4.940*	3.14 Profit of 791 on sale
2025-03-14	SELL	-1,360	4.950*	2.72 Profit of 3,702 on sale
2025-03-07	SELL	-170	2.660*	2.57 Profit of 436 on sale
2025-03-04	SELL	-85	2.600*	2.55 Profit of 217 on sale
2025-02-25	BUY	170	2.620*	2.55
2025-02-19	SELL	-85	2.570*	2.54 Profit of 216 on sale
2025-02-13	BUY	255	2.550*	2.55
2025-02-12	BUY	85	2.390*	2.55
2025-02-11	BUY	340	2.330*	2.56
2025-01-17	BUY	340	2.610*	2.57
2025-01-16	BUY	340	2.440*	2.59
2025-01-10	SELL	-170	2.490*	2.78 Profit of 473 on sale
2025-01-08	SELL	-340	2.690*	2.96 Profit of 1,006 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of TSVT

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-05-12	347,814	9,039	457,421	76.0%
2025-05-09	23,539	0	58,761	40.1%
2025-05-08	95,836	1,642	144,325	66.4%
2025-05-07	65,815	0	106,501	61.8%
2025-05-06	119,660	0	365,378	32.7%
2025-05-05	197,065	850	617,734	31.9%
2025-05-02	220,151	2,550	632,146	34.8%
2025-05-01	132,120	0	352,841	37.4%
2025-04-30	118,918	0	356,759	33.3%
2025-04-29	69,365	0	143,962	48.2%
2025-04-28	53,913	0	124,933	43.2%
2025-04-25	42,104	0	112,634	37.4%
2025-04-24	81,034	0	185,379	43.7%
2025-04-23	163,013	0	345,812	47.1%
2025-04-22	85,077	0	215,910	39.4%
2025-04-21	115,652	101	414,037	27.9%
2025-04-17	32,822	0	156,151	21.0%
2025-04-16	55,228	6,793	133,432	41.4%
2025-04-15	85,708	0	164,104	52.2%
2025-04-14	130,415	0	297,504	43.8%
2025-04-11	37,781	0	305,946	12.3%
2025-04-10	214,675	0	273,625	78.5%
2025-04-09	266,329	0	422,413	63.0%
2025-04-08	640,176	500	1,330,515	48.1%
2025-04-07	270,949	406	575,701	47.1%
2025-04-04	268,571	4,227	530,652	50.6%
2025-04-03	195,438	276	501,980	38.9%
2025-04-02	59,306	1	140,615	42.2%
2025-04-01	116,815	300	267,163	43.7%
2025-03-31	255,068	0	415,797	61.3%
2025-03-28	54,324	15,700	148,105	36.7%
2025-03-27	187,126	36,200	441,024	42.4%
2025-03-26	203,990	0	443,448	46.0%
2025-03-25	55,277	0	182,998	30.2%
2025-03-24	138,562	132	344,489	40.2%
2025-03-21	89,616	5,500	194,425	46.1%
2025-03-20	119,182	0	324,671	36.7%
2025-03-19	139,426	0	238,080	58.6%
2025-03-18	156,318	0	353,181	44.3%
2025-03-17	325,195	9,982	859,359	37.8%
2025-03-14	99,376	0	713,686	13.9%
2025-03-13	218,567	749	709,443	30.8%
2025-03-12	454,415	2,186	2,012,337	22.6%
2025-03-11	5,329,782	20,600	17,870,821	29.8%
2025-03-10	60,415	13	218,081	27.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	BTEC(USD) LSE
ETF Ticker	BTEK(GBP) LSE
ETF Ticker	2B70(EUR) F
ETF Ticker	2B70.DE(EUR) CXE
ETF Ticker	BTEC.LS(USD) CXE
ETF Ticker	BTEK.LS(GBP) CXE
ETF Ticker	BTEC.L(GBP) LSE
ETF Ticker	BTEK.L(GBP) LSE